Providing more evidence on LZTR1 variants in Noonan syndrome patients.
Josefina ChintonVictoria HuckstadtMafalda MuccioloFrancesca Romana LepriAntonio NovelliLuis Pablo GravinaMaría Gabriela ObregonPublished in: American journal of medical genetics. Part A (2019)
Noonan syndrome (NS, OMIM 163950) is a common autosomal dominant RASopathy caused mainly by gain-of-function germline pathogenic variants in genes involved in the RAS/MAPK signaling pathway. LZTR1 gene has been associated with both dominant and recessive NS. Here, we present seven patients with NS and variants in the LZTR1 gene from seven unrelated families, 14 individuals in total. The detection rAte of LZTR1 variants in our NS cohort was 4% similar to RAF1 and KRAS genes, indicating that variants in this gene might be frequent among our population. Three different variants were detected, c.742G>A (p.Gly248Arg), c.360C>A (p.His120Gln), and c.2245T>C (p.Tyr749His). The pathogenic variant c.742G>A (p.Gly248Arg) was found in five/seven patients. In our cohort 50% of patients presented heart defects and neurodevelopment delay or learning disabilities, short stature was present in 21% of them and one patient had acute lymphoblastic leukemia. This study broadens the spectrum of variants in the LZTR1 gene and provides increased knowledge of the clinical phenotypes observed in Argentinean NS patients.
Keyphrases
- copy number
- end stage renal disease
- chronic kidney disease
- ejection fraction
- signaling pathway
- acute lymphoblastic leukemia
- prognostic factors
- peritoneal dialysis
- heart failure
- genome wide
- dengue virus
- case report
- autism spectrum disorder
- genome wide identification
- dna repair
- allogeneic hematopoietic stem cell transplantation